Back
Stoneridge, Inc. 10K Form
Sell
31
SRI
Stoneridge, Inc.
Last Price:
$5.87
Seasonality Move:
0.99%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-05-01 | 10Q | SRI/Stoneridge, Inc. Quarterly |
| 2023-11-01 | 10Q | SRI/Stoneridge, Inc. Quarterly |
| 2023-08-02 | 10Q | SRI/Stoneridge, Inc. Quarterly |
| 2023-05-03 | 10Q | SRI/Stoneridge, Inc. Quarterly |
| 2022-11-02 | 10Q | SRI/Stoneridge, Inc. Quarterly |
| 2022-08-03 | 10Q | SRI/Stoneridge, Inc. Quarterly |
Receive SRI News And Ratings
See the #1 stock for the next 7 days that we like better than SRI
SRI Financial Statistics
Sales & Book Value
| Annual Sales: | $908.3M |
|---|---|
| Cash Flow: | $-2.7M |
| Price / Cash Flow: | 6.93 |
| Annual Sales: | $8.97 |
| Price / Book: | 0.65 |
Profitability
| EPS (TTM): | -1.15400 |
|---|---|
| Net Income (TTM): | $-32M |
| Gross Margin: | $182.1M |
| Return on Equity: | -12.5% |
| Return on Assets: | -4.99% |
Stoneridge, Inc. Earnings Forecast
Key Stoneridge, Inc. Financial Ratios
-
The Gross Profit Margin over the past 29 years for SRI is 20.04%.
-
The Selling, General & Administrative Expenses for SRI have been equal to 12.93% of Gross Profit Margin.
-
The Research & Development expenses have been 7.78% of Revenue.
-
The Net Earning history of SRI is -1.82% of Total Revenues.
-
Per Share Earnings over the last 29 years have been positive in 16 years.
Stoneridge, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NYSE |
|---|---|
| Industry: | Automobile Components |
| Sector: | Consumer Discretionary |
| Current Symbol: | SRI |
| CUSIP: | 86183P |
| Website: | stoneridge.com |
Debt
| Debt-to-Equity Ratio: | 0.72 |
|---|---|
| Current Ratio: | 2.13 |
| Quick Ratio: | 1.15 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 32.31 |
SRI Technical Analysis vs Fundamental Analysis
Sell
31
Stoneridge, Inc. (SRI)
is a Sell
Is Stoneridge, Inc. a Buy or a Sell?
-
Stoneridge, Inc. stock is rated a SellThe current Stoneridge, Inc. [SRI] share price is $5.87. The Score for SRI is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.